Peer Review History

Original SubmissionDecember 22, 2020
Decision Letter - Ukachukwu Okoroafor Abaraogu, Editor

PONE-D-20-40047

Review of Exercise Testing in Patients with Intermittent Claudication: A Focus on Test Standardisation and Reporting Quality

PLOS ONE

Dear Dr. Pymer,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

I agree with all reviewer comments and invite authors to respond to each of them.

Authors should further justify why they choose only RCT trials since this is not an interventional review. include other study designs(preferably) or reflect in the title and elsewhere that this is a review of RCTs. Clarify the statement "studies that randomised patients to an exercise or comparator arm following revascularisation without a non-invasive exercise arm, were also excluded" is not quite clear. Provide a better contextualisation of the reason for including only studies published between 1995-2020 given the meta analyses by Gardener and Poehlman, had a different focus from this review. Upgrade the supplementary Table 1 with more specific details focus of the review.

Provide rationale why the review is only focused studies of exercise interventions included in review given that treadmill testing is commonly used in other non-exercise interventions for this population? Fully present the full analysis and rating of the studies included e.g. in table format to enhance transparency and make it easier for the reader to see how each study has been evaluated.

Please submit your revised manuscript by 12th of April 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Ukachukwu Okoroafor Abaraogu, BMR PT, MSc, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This systematic review aimed to 1) assess the terminology used to describe MWD, 2) examine the various testing protocols used in exercise interventions, and 3) assess the implementation and reporting of exercise testing protocols using adapted recommendations and guidelines for patients with IC. The authors concluded that currently there is significant heterogeneity in terminology, protocols and reporting of exercise testing in trials of people with PAD and IC.

This is the first review of its type and contributes important information that should encourage and enable improvements in the design, implementation and reporting of exercise testing in this population.

The strengths of this manuscript include that it presents a clear introduction and establishment of the rationale/ gap in the literature. Weaknesses of this manuscript include the limited explanation of methodological choices e.g. why only studies of exercise interventions included in review? There is a lack of presentation of full analysis and rating of the studies included e.g. in table format. This would enhance transparency and make it easier for the reader to see how each study has been evaluated.

Major issues-

None.

Minor issues-

Exclusion of studies other than on exercise interventions. Perhaps the authors could review the methods to clearly state the rationale for exclusion of non-exercise intervention RCTs or re-run the search/ include studies of interventions other than exercise. Exercise testing is used in PAD and IC research for multiple interventions and this may allow a more comprehensive summary of the current use of exercise testing in PAD and IC research. If not including/ changing methods then this should be addressed in the limitations section.

Presentation of full data/ analysis of included studies. The authors might consider including a table summarising the findings for all studies. This is currently presented in the text but might be mor informative/ easier for the reader to navigate in table form and collected according to study.

Minors inconsistency issues in use of SWT and ISWT abbreviations on pages 6 and 7.

Repetitions of reference in list – Hiatt et al 2005 is included twice (10 and 20). Perhaps review full list for any other inaccuracies.

Reviewer #2: The manuscript, "Review of Exercise Testing in Patients with Intermittent Claudication: A Focus on Test Standardisation and Reporting Quality" reports an important aspect of PAD assessment. The topic is well justified, well written and interesting.

However, I have a few remarks;

I believe that RCTS of clinical trials or simply trial should also come in the title. And the authors should further justify why they choose only RCT trials since this is not an interventional review. Next, in the inclusion criteria, the statement "studies that randomised patients to an exercise or comparator arm following revascularisation without a non-invasive exercise

arm, were also excluded" is not quite clear. What does the authors mean by non-invasive exercise and of what relevance is it the review?

furthermore, Only full-text articles published from 1995 up to June 2020 were included, and the reason for this was based upon a a meta analyses by Gardener and Poehlman, which has a different focus from this review. You need a better reason.

The supplementary Table 1 is quite scanty and not in line with the focus of the review. Please upgrade this with more specific details.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: chris seenan

Reviewer #2: Yes: Jibril Mohammed

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Mr Sean Pymer

Academic Vascular Surgical Unit

Hull York Medical School

Hull, UK

Dear Dr. Abaraogu

RE: Manuscript ID: PONE-D-20-40047

We wish to thank the reviewers, Chris Seenan and Jibril Mohammed, for their time and efforts in reviewing our manuscript. You kindly summarised the main points from the reviewers, with no additional comments, so we hope that by responding to the reviewer’s comments, we will also have covered the points you raised.

Reviewer #1:

Comment: Exclusion of studies other than on exercise interventions. Perhaps the authors could review the methods to clearly state the rationale for exclusion of non-exercise intervention RCTs or re-run the search/ include studies of interventions other than exercise. Exercise testing is used in PAD and IC research for multiple interventions, and this may allow a more comprehensive summary of the current use of exercise testing in PAD and IC research. If not including/ changing methods, then this should be addressed in the limitations section.

Response: We absolutely agree with this comment, however, we felt that if we included these studies, the review would have been unmanageable and potentially overwhelming for the reader. We also felt that the addition of these studies would not alter our findings. We have therefore added some additional detail in the methods section “exclusion of these studies, and non-RCT's, is in line with a previous review on reporting standards and also ensured that the current review and the number of included studies was manageable” and the limitations section as suggested, “finally, we excluded certain studies, such as those that included exercise performed after revascularisation. However, this ensured that the review was manageable and as 64 trials were still included in spite of this, it is unlikely that including these studies would have altered our findings”. Many thanks for this suggestion.

Comment: Presentation of full data/ analysis of included studies. The authors might consider including a table summarising the findings for all studies. This is currently presented in the text but might be more informative/ easier for the reader to navigate in table form and collected according to study.

Response: Yes, we agree, and clarity is important. We have added the analysis and scoring of included studies in a table format. However, given this created seven new tables we have added these as supplementary materials (tables 3 and 4).

Comment: Minor inconsistency issues in use of SWT and ISWT abbreviations on pages 6 and 7.

Response: Many thanks for spotting this mistake, we have amended the manuscript accordingly.

Comment: Repetitions of reference in list – Hiatt et al 2005 is included twice (10 and 20). Perhaps review full list for any other inaccuracies

Response: This has now been rectified. Thankyou.

Reviewer #2:

Comment: I believe that RCTS of clinical trials or simply trial should also come in the title. And the authors should further justify why they choose only RCT trials since this is not an interventional review.

Response: Many thanks for this comment. We have now updated the title to “Review of Exercise Testing in Patients with Intermittent Claudication: A Focus on Test Standardisation and Reporting Quality in Randomised Controlled Trials”. We chose to exclude non-RCT’s in line with a previous review of reporting quality published in PLOS One (1). We also felt that this would ensure that the review was manageable and not overwhelming for the reader. Finally, standardised reporting is of the greatest importance in RCT’s as these often inform clinical practice or are used to generate level 1a evidence which does inform clinical practice. We have added the following sentence to the methods section “exclusion of these studies, and non-RCT's, is in line with a previous review on reporting standards and also ensured that the current review and the number of included studies was manageable”.

Comment: Next, in the inclusion criteria, the statement "studies that randomised patients to an exercise or comparator arm following revascularisation without a non-invasive exercise arm, were also excluded" is not quite clear. What does the authors mean by non-invasive exercise and of what relevance is it the review?

Response: We appreciate this comment and agree that this sentence is not as clear as it could be. To clarify, by non-invasive exercise arm, we meant an initial randomisation to exercise therapy or revascularisation, rather than post-revascularisation randomisation (i.e. randomised to revascularisation or exercise, rather than to exercise or control after revascularisation). We have edited this sentence to state “studies that randomised patients to an exercise or comparator arm following revascularisation were also excluded"

Comment: Furthermore, only full-text articles published from 1995 up to June 2020 were included, and the reason for this was based upon a meta analyses by Gardener and Poehlman, which has a different focus from this review. You need a better reason.

Response: We appreciate this comment, but our aim was to ensure that the review was manageable and not overwhelming to the reader. We felt that the 25-year period was sufficient especially given the increase in exercise-based trials in recent years. This is demonstrated in our results whereby we still included 64 studies. We have also added the following to the methods section “we excluded studies that were published prior to 1995 as the majority of exercise programmes after this date were based on a specific meta-analysis (14) and we felt that the period of 25 years would provide sufficient information to inform our findings, especially given the increase in exercise-based trials in recent years”.

Comment: The supplementary Table 1 is quite scanty and not in line with the focus of the review. Please upgrade this with more specific details.

Response: We have now added specific details regarding the exercise intervention and control (when available). Thankyou

We appreciate the opportunity to revise our manuscript and again wish to thank the reviewers and yourself.

Yours Sincerely,

Mr Sean Pymer – on behalf of all authors

Reference:

1. Tew GA, Brabyn S, Cook L, Peckham E. The Completeness of Intervention Descriptions in Randomised Trials of Supervised Exercise Training in Peripheral Arterial Disease. PLOS ONE. 2016;11(3):e0150869.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Ukachukwu Okoroafor Abaraogu, Editor

A Systematic Review of Exercise Testing in Patients with Intermittent Claudication: A Focus on Test Standardisation and Reporting Quality in Randomised Controlled Trials

PONE-D-20-40047R1

Dear Dr. Pymer,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ukachukwu Okoroafor Abaraogu, BMR PT, MSc, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Congratulation on the revision. I am happy to 'conditionally' accept the manuscript but will like a further very minor revison before the manuscript goes to the production stage

Therefore, I will like the authors to specify in the title and also give a few sentenses in the introcuction to point to te fact that only exercise intervention were reviewed. I agree that the review results may or may not be different when other interventions and research design are included. It is only cautionary to define and describe review title, aim, methods, and findings within the limits of the review scope and the empirical evidence generated.

Reviewers' comments:

Formally Accepted
Acceptance Letter - Ukachukwu Okoroafor Abaraogu, Editor

PONE-D-20-40047R1

A Systematic Review of Exercise Testing in Patients with Intermittent Claudication: A Focus on Test Standardisation and Reporting Quality in Randomised Controlled Trials Including Exercise Interventions

Dear Dr. Pymer:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Ukachukwu Okoroafor Abaraogu

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .